Measurement of HTL0016878 in Cerebrospinal Fluid

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

December 7, 2018

Study Completion Date

December 7, 2018

Conditions

Healthy Subjects

Interventions

DRUG

HTL0016878

Oral solution

Trial Locations (1)

MAC Clinical Research, Manchester

All Listed Sponsors

lead

Nxera Pharma UK Limited

INDUSTRY

NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid | Biotech Hunter | Biotech Hunter